|4/AMar 29, 6:12 AM ET

Bozigian Haig P. 4/A

4/A · NEUROCRINE BIOSCIENCES INC · Filed Mar 29, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-05
Bozigian Haig P.
Sr Vice President, Development
Transactions
  • Award

    Stock Option

    2021-02-08+3,5043,504 total
    Exercise: $117.43Exp: 2031-02-08Common Stock (3,504 underlying)
Footnotes (1)
  • [F1]Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 8, 2021 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION